Jaguar Health Reports Third Quarter 2023 Financial Results
Net revenue increased 5% in Q3 2023 versus Q2 2023Top line results expected before Thanksgiving for company's phase 3 OnTarget...
Mental Health
QHSLab, Inc. (USAQ) Reports Third Quarter Financial Results
25% Y-O-Y Revenue Growth in Q3 2023 Compared to Q3 2022 and 51% Increase in Gross Profit. ●In Q3 2023,...
Acentra Health Awarded New Contract Supporting Utilization Management and Assessment Services for West Virginia Medicaid
Award builds on company’s 23-year state partnership to accelerate better health outcomes for Medicaid membersMCLEAN, Va., Nov. 14, 2023 (GLOBE...
atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights
Phase 2b study of RL-007 in CIAS patients continues to be on track to report data in 2H 2024 and...
Will Campbell, CEO of Quantasy, Speaks on the Power of Mental Wellness in “Breaking and Entering Advertising” Podcast
LOS ANGELES, Nov. 13, 2023 /PRNewswire/ -- In the ever-evolving world of advertising, success is often measured by creativity, innovation,...
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
New updates designed to advance practice efficiency and patient outcomesMALVERN, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...
VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Transformative capital raise of $88.2 million from leading healthcare investors provides funding for BET inhibitor programs through the end of...
Kollab Youth Partners With Mental Health Technologies
Collaborating in Providing Mental Health Testing for Under-Resourced Middle and High School StudentsAURORA, IL / ACCESSWIRE / November 9, 2023...
Breast Cancer Related Results of Groundbreaking Napo Pharmaceuticals (a Jaguar Health Family Company) Supported Study on Quality of Life for Cancer Patients and Survivors Accepted for Presentation at the December 2023 San Antonio Breast Cancer Symposium
SAN FRANCISCO, CA / ACCESSWIRE / November 9, 2023 / Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company,...
World’s First Observational Trial to Assess Real-World Efficacy of MDMA Treatment
PharmAla, University of Calgary, and Heroic Hearts Canada to partner on a groundbreaking observational trialVANCOUVER, British Columbia, Nov. 09, 2023...
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
Policy Updates from Magellan and Two Additional Payors Increase Access for 3.2 Million Covered LivesMALVERN, Pa., Nov. 09, 2023 (GLOBE...
Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq’s Bid Price Rule
SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced...
Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates
Click here to register for November 14 investor webcastCompany plans to file its Earnings Report on November 14, 2023 on...
As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
Company Introduces Multimedia Resources to Bring Awareness of SADLAVAL, QC / ACCESSWIRE / November 8, 2023 / As daylight saving...
ReflexAI Introduces HomeTeam to Revolutionize Veteran Mental Health Support
The first-of-its-kind, AI-powered training tool launches ahead of Veterans Day with the goal of improving the lives of veterans across...
futuresTHRIVE Launches Game-Changing AI Platform to Transform Youth Mental Health Screening
Insights from Recent Research Study Expose Significant Gaps in Standard of CareDARIEN, Conn., Nov. 08, 2023 (GLOBE NEWSWIRE) -- futuresTHRIVE,...
eClinicalWorks Cloud EHR Improves Operational Efficiency for 134-Provider Federally Qualified Health Center
CA-based practice sees success and improved patient engagement with the multi-dimensional eClinicalWorks V12WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR,...
Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis at American College of Rheumatology Convergence Annual Meeting
− The Study Met Its Primary Endpoint with 53.3% and 54.2% of Patients Treated With TAK-279 (15 mg and 30...
REMINDER: Jaguar Health to Host Virtual Educational Webinar on Rare Intestinal Failure Diseases with Leading Gastroenterologists and Nutrition Experts November 8th from 1:00 PM to 2:30 PM EST
Click here to register for webinarSAN FRANCISCO, CA / ACCESSWIRE / November 7, 2023 / Napo Pharmaceuticals (Napo), a Jaguar...
Innovative Renal Care and DeLorean AI Forge Historic Partnership to Revolutionize Kidney Care With Artificial Intelligence
Pioneering AI-Driven Patient Care to Elevate Outcomes and Transform Lives in the Dialysis SpaceMIAMI, FL / ACCESSWIRE / November 7,...